Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +7.14%. A quarter ago, it was expected that this orthopedic medical device maker would post a loss of $0.29 per share when it actually produced a loss of $0.28, delivering a surprise of +3.45%.Over the last four ...